Literature DB >> 29631245

Maintenance ECT in schizophrenia: A systematic review.

Heather Burrell Ward1, Steven T Szabo2, Gopalkumar Rakesh3.   

Abstract

Relapse after discontinuation of ECT is significant in patients with schizophrenia. The purpose of this systematic review was to examine use of M-ECT in schizophrenia to guide clinical decision making for relapse prevention in schizophrenia. We reviewed studies examining the role of continuation (C-ECT) and maintenance electroconvulsive therapy (M-ECT) in schizophrenia. Following PRISMA guidelines, we included randomized controlled trials, open label trials, retrospective chart reviews, case reports, and case series in this review. We evaluated adjunctive pharmacological regimens; ECT treatment parameters, including frequency, duration of continued treatment, electrode placement; clinical outcomes including cognitive side effects and relapse rates from included studies. Our findings suggest M-ECT could provide an effective form of relapse prevention in these patients and persistent cognitive side effects are minimal.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Maintenance electroconvulsive therapy; Relapse prevention; Schizophrenia

Mesh:

Year:  2018        PMID: 29631245     DOI: 10.1016/j.psychres.2018.03.033

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  7 in total

1.  [Health service aspects of electroconvulsive therapy: analysis of external referrals to a university medical center].

Authors:  Isabel Methfessel; Michael Belz; Fabienne Bühler; David Zilles-Wegner
Journal:  Nervenarzt       Date:  2022-08-11       Impact factor: 1.297

2.  Comparison of Acute Followed by Maintenance ECT vs Clozapine on Psychopathology and Regional Cerebral Blood Flow in Treatment-Resistant Schizophrenia: A Randomized Controlled Trial.

Authors:  Biswa Ranjan Mishra; Kanhaiyalal Agrawal; Tathagata Biswas; Debadatta Mohapatra; Santanu Nath; Rituparna Maiti
Journal:  Schizophr Bull       Date:  2022-06-21       Impact factor: 7.348

3.  Treatment Capacity and Clinical Outcomes for Patients With Schizophrenia Who Were Treated With Electroconvulsive Therapy: A Retrospective Cohort Study.

Authors:  Joanne E Plahouras; Gerasimos Konstantinou; Tyler S Kaster; Daniel Z Buchman; George Foussias; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

4.  Effectiveness of maintenance electroconvulsive therapy-Evidence from modifications due to the COVID-19 pandemic.

Authors:  Isabel Methfessel; Matthias Besse; Michael Belz; David Zilles-Wegner
Journal:  Acta Psychiatr Scand       Date:  2021-05-18       Impact factor: 7.734

5.  Relapse after abrupt discontinuation of maintenance electroconvulsive therapy during the COVID-19 pandemic.

Authors:  Simon Lambrichts; Kristof Vansteelandt; Bo Crauwels; Jasmien Obbels; Eva Pilato; Jonas Denduyver; Katrien Ernes; Pieter-Paul Maebe; Charlotte Migchels; Lore Roosen; Satya Buggenhout; Filip Bouckaert; Didier Schrijvers; Pascal Sienaert
Journal:  Acta Psychiatr Scand       Date:  2021-06-28       Impact factor: 7.734

6.  Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A Retrospective Cohort Study.

Authors:  Moshe Isserles; Jesse Remington; Tyler S Kaster; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  J ECT       Date:  2020-03       Impact factor: 3.692

7.  Polymorphisms in MicroRNA Genes Associated with Schizophrenia Susceptibility but Not with Effectiveness of MECT.

Authors:  Danwei Zhang; Huihua Li; Kaimo Ding; Zhen Zhang; Si Luo; Guohai Li
Journal:  Comput Math Methods Med       Date:  2021-12-13       Impact factor: 2.238

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.